Trial intelligence / Profile preview

Glimepiride vs Sitagliptin in Naïve Type 2 Diabetes (SUMER)

NCT00957060Phase 4Completed

Sponsor
Sanofi
Start
Jul 2009
Primary completion
Oct 2010
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 4 trial of glimepiride in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jul 2009; status: completed.

02

Drugs

glimepiride
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00957060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00957060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call